Characterization of keratin and cell cycle protein expression in cell lines from squamous intraepithelial lesions progressing towards a malignant phenotype

British Journal of Cancer

Volumn 77, Issue 5, 1998, Pages 766-775

  Hietanen, S ^a,b   Syrjanen K ^c   Syrjanen S ^c,d  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

Human papillomavirus; Malignant progression; Multistep carcinogenesis; Organotypic culture

Indexed keywords

CELL CYCLE PROTEIN; KERATIN; PROTEIN P21; VIRUS MESSENGER RNA;

ARTICLE; CELL STRUCTURE; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL LINE; WART VIRUS;

EID: 0031886447     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.125     Document Type: Article

References (45)

1. Aho M, Vesterinen E, Meyer B, Purola E and Paavonen J (1991) Natural history of vaginal intraepithelial neoplasia. Cancer 68: 195-197
2. Angus B, Kiberu S, Purvis J, Wilkinson L and Horne CH (1988) Cytokeratins in cervical dysplasia and neoplasia: a comparative study of immunohistochemical staining using monoclonal antibodies NCL-5D3, CAM 5.2, and PKKI. J Pathol 155: 71-75
3. Bravo R, Frank R, Blundell PA and MacDonald Bravo H (1987) Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 326: 515-517
4. Cheng S, Scmidt-Grimminger D, Murant T, Broker TR and Chow LT (1995) Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev 9: 2335-2349
5. Chomoczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
6. Cintorino M, Petracca R, Vindigni C, Tripodi SA and Leoncini P (1990) Topography-related expression of individual cytokeratins in normal and pathological (non-neoplastic and neoplastic) human oral mucosa. Virchows Arch A Pathol Anat Histopathol 417: 419-426
7. Crook T, Tidy JA and Vousden KH (1991) Degradation of p53 can be targeted by HPV E6 sequences distinct from those required lor p53 binding and transactivation. Cell 67: 547-556
8. Crook T, Fisher C, Masterson PJ and Vousden KH (1994) Modulation of transcriptionial regulatory properties of p53 by HPV E6. Oncogene 9: 1225-1230
9. Demeter LM, Stoler MH, Broker TR and Chow LT (1994) Induction of proliferating cell nuclear antigen in differentiated keratinocytes of human papillomavirus-infected lesions (see comments). Hum Pathol 25: 343-348
10. Gilles C, Piette J, Peter W. Fusenig NE and Foidart JM (1994) Differentiation ability and oncogenic potential of HPV-33 - and HPV-33 + ras-transfected keratinocytes. Int J Cancer 58: 847-854
11. Gloss B, Bernard HU, Seedorf K and Klock G (1987) The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J 6: 3735-3743
12. Hall PA and Lane DP (1997) Tumor suppressors: a developing role for p53. Curr Biol 7: 144-147
13. Hall PA, Mckee PH, Menage HD, Dover R and Lane DP (1993) High levels of p53 protein in UV-irradiated normal human skin. Oncogene 8: 203-207
14. Hietanen S, Auvinen E, Grénman S, Lakkala T, Sajantila A, Klemi P and Mäenpää J (1992) Isolation of two keratinocyte cell lines derived from HPV-positive dysplastic vaginal lesions. Int J Cancer 52: 391-398
15. Hietanen SH, Kurvinen K, Syrjänen K, Grénman S, Carey T, McClatchey K and Syrjänen S (1995) Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells. Am J Obstet Gynecol 173: 1477-1482
16. Ikenberg H, Matthay K, Schmitt B, Bauknecht T, Kiechleschwarz M, Goppinger A and Pfleiderer A (1995) p 53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas. Cancer 76: 57-66
17. Kataja V, Syrjänen S, Mäntyjärvi R, Yliskoski M, Saarikoski S and Syrjanen K (1942) Prognostic factors in cervical human papillomavirus infections. Sex Transm Dis 19: 154-160
18. Kessis TD, Slebos RJ, Nelson WG, Kastan MB, Plunkett BS, Han SM, Lorinez AT, Hedrick L and Cho KR (1993) Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to. Proc Natl Acad Sci USA 90: 3988-3992
19. Kurvinen K, Syrjänen K and Syrjänen S (1996) p53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions. J Clin Oncol 14: 2120-2130
20. Lechner MS and Laimins LA (1994) Inhibition of p53 ONA binding by human papillomavirus E6 proteins. J Virol 68: 4262-4273
21. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B and Jacks T (1995) p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 9: 935-944
22. Marchetti A, Doglioni G, Barbareschi M, Buttitta F, Pellegrini S, Bertacca G, Chella A, Merlo G, Angeletti CA, Dallapalma P and Bevilacqua G (1996) p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. Oncogene 12: 1319-1324
23. Martin K, Trouche D, Sorensen TS, Lathangue NB and Kouzarides T (1995) Stimulation of E21F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 375: 691-694
24. McDougall JK (1994) Immortalization and transformation of human cells by human papillomavirus. Curr Top Microbiol Immunol 186: 101-119
25. Merrick DT, Blanton RA, Gown AM and McDougall JK (1992) Altered expression of proliferation and differentiation markers in human papillomavirus 16 and 18 immortalized epithelial cells grown in organotypic culture. Am J Pathol 140: 167-177
26. Missero C, Calautti E, Eckner R, Chin J, Tsai LH, Livingston DM and Dotto GP (1995) Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci USA 92: 5451-5455
27. Mittal R, Pater A and Pater MM (1993) Multiple human papillomavirus type 16 glucocorticoid response elements functional for transformation, transient expression, and DNA-protein interactions. J Virol 67: 5656-5659
28. Moles JP, Schiller JT, Tesniere A, Leigh IM, Guilhou JJ and Basset Seguin N (1994) Analysis of HPV16 E6 and mutant p53-transfected keratinocytes in reconstituted epidermis suggests that wild-type p53 inhibits cytokeratin 19 expression. J Cell Sci 107: 435-441
29. Molinari M and Milner J (1995) p53 in complex with DNA is resistant to ubiquitin-dependent proteolysis in the presence of HPV-16 E6. Oncogene 10: 1849-1854
30. Moll R, Franke WW, Schiller DL, Geiger B and Krepler R (1982) The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31: 11-24
31. Momand J, Zambetti GP, Olson DC, George D and Levine AJ (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245
32. Oliner JD, Kinzler KW, Meltzer PS, George DL and Vogelstein B (1992) Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358: 80-83
33. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olson EN, Harper JW and Elledge SJ (1995) p53-independent expression of p21 Cip1 in muscle and other terminally differentiating cells. Science 267, 1024-1027
34. Prelich G, Tan CK, Kostura M, Mathews MB, So AG, Downey KM and Stillman B (1987) Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature 326: 517-520
35. Proby CM, Churchill L, Purkis PE, Glover MT, Sexton CJ and Leigh IM (1993) Keratin 17 expression as a marker for epithelial transformation in viral warts. Am J Pathol 143: 1667-1678
36. Scheffner M, Huibregtse JM, Vierstra RD and Howley PM (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75: 495-505
37. Shivji KK, Kenny MK and Wood RD (1992) Proliferating cell nuclear antigen is required for DNA excision repair. Cell 69: 367-374
38. Smedts F, Ramaekers F, Robben H, Pruszczynski M, Van Muijen G, Lane B, Leigh I and Vooijs P ( 1990) Changing patterns of keratin expression during progression of cervical intraepithelial neoplasia. Am J Pathol 136: 657-668
39. Smedts F, Ramaekers F, Troyanovsky S, Pruszczynski M, Link M, Lane B, Leigh I, Schijf C and Vooijs P (1992a) Keratin expression in cervical cancer. Am J Pathol 141: 497-511
40. Smedts F, Ramaekers F, Troyanovsky S, Pruszczynski M, Robben H, Lane B, Leigh I, Plantema F and Vooijs P (1992b) Basal-cell keratins in cervical reserve cells and a comparison to their expression in cervical intraepithelial neoplasia. Am J Pathol 140: 601-612
41. Smedts F, Ramaekers FC and Vooijs PG (1993) The dynamics of keratin expression in malignant transformation of cervical epithelium: a review. Obstet Gynecol 82: 465
42. Sun Q, Tsutsumi K, Yokoyama M, Pater MM and Pater A (1993) In vivo cytokeratin-expression pattern of stratified squamous epithelium from human papillomavirus-type-16-immortalized ectocervical and foreskin keratinocytes. Int J Cancer 54: 656-662
43. Syrjänen S, Cintorino M, Armellini D, Del Vecchio MT, Leoncini P, Bugnoli M, Pallini V, Silvestri S, Tosi P, Mäntyjärvi R and Syrjänen K (1988) Expression of cytokeratin polypeptides in human papillomavirus (HPV) lesions of the uterine cervix. I. Relationship to grade of CIN and HPV type. Int J Gynecol Pathol 7: 23-28
44. Weir-Thompson E, Condie A, Leonard RC and Prosser J (1991) A familial RBI mutation detected by the HOT technique is homozygous in a second primary neoplasm. Oncogene 6: 2353-2356
45. Xiao ZX, Chen JD, Levine AJ, Modjtahedi N, Xing J, Sellers WR and Livingston DM (1995) Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375: 694-698